FM EOR Review Flashcards
(254 cards)
What is the MC initial presentation of type 1 DM?
What is the 2nd MC?
MC = Hyperglycemia without acidosis with polyuria, polydipsia, polyphagia
2nd MC = DKA
What are the rapid-acting insulins?
Lispro (Humalog)
Aspart (Novalog)
Glulisine (Apidra)
What is the short-acting insulin?
Regular
What is the intermediate-acting insulin?
NPH
What are the long-acting insulins?
Glargine (Lantus)
Determir (Lemevir)
What is the MC cause of DKA?
Infection
What is the triad of DKA?
hyperglycemia, ketonemia, acidosis (rapid onset)
What is the presentation of DKA? (8)
3 Ps (Polyuria, Polyphagia, Polydipsia) Fatigue AMS Abdominal pain Tachycardia Hypotension Fruity breath Kussmaul respirations
What is the treatment of DKA? (4)
- Isotonic 0.9% NS until hypotension resolves. Then switch to 1/2 NS. When glucose level becomes less than 250, switch to D5 to prevent hypoglycemia from insulin therapy
- Regular insulin
- Potassium repletion
- Search for underlying cause
What are RF for type 2 DM?
Obesity, decreased physical activity, genetics
What are the screening guidelines for DM?
All adults ≥ 45 yo every 3 yrs OR any adult with BMI ≥ 25 + 1 risk factor
What diagnostic findings indicate DM?
- Fasting Plasma Glucose ≥ 126 (GOLD STANDARD)
- 2-hour Glucose Tolerance Test ≥ 200
- HbA1C ≥ 6.5%
What is the MOA of Metformin?
Decreases hepatic glucose production, increases insulin sensitivity
What are benefits of Metformin?
Reduces risk of CV death, lowers LDL
What are SE of Metformin?
Diarrhea, lactic acidosis, B12 deficiency
What are CI of Metformin?
Severe renal (GFR < 30) or hepatic impairment Heart failure
What is the MOA of Sulfonylureas?
Stimulates non glucose dependent insulin secretion
Which Sulfonylureas are used most commonly?
2nd generation (Glipizide, Glimepiride, Glyburide) *Glyburide has the highest risk of hypoglycemia
What are SE of Sulfonylureas?
Hypoglycemia
Weight gain
What is the MOA of Thiazolidinediones “-glitazone”?
Increase insulin sensitivity
What are SE of Thiazolidinediones “-glitazone”? (5)
Peripheral edema Fluid retention/weight gain CHF Hepatotoxicity Increased fractures (females)
What are CI of Thiazolidinediones “-glitazone”? (5)
Heart failure
Hx of bladder cancer
Liver disease
Pregnancy
What is the MOA of GLP1 Receptor agonists “-tide”?
Increases glucose dependent insulin secretion, delays gastric emptying, decreases glucagon secretion
What are SE of GLP1 Receptor agonists “-tide”?
Hypoglycemia (less than sulfonylureas), pancreatitis